000 | 01253 a2200337 4500 | ||
---|---|---|---|
005 | 20250514221825.0 | ||
264 | 0 | _c20050331 | |
008 | 200503s 0 0 eng d | ||
022 | _a1473-3099 | ||
024 | 7 |
_a10.1016/S1473-3099(05)01307-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGroneberg, David A | |
245 | 0 | 0 |
_aTreatment and vaccines for severe acute respiratory syndrome. _h[electronic resource] |
260 |
_bThe Lancet. Infectious diseases _cMar 2005 |
||
300 |
_a147-55 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
650 | 0 | 4 |
_aDisease Outbreaks _xprevention & control |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aSevere acute respiratory syndrome-related coronavirus _xdrug effects |
650 | 0 | 4 |
_aSevere Acute Respiratory Syndrome _xdrug therapy |
650 | 0 | 4 | _aViral Vaccines |
700 | 1 | _aPoutanen, Susan M | |
700 | 1 | _aLow, Donald E | |
700 | 1 | _aLode, Hartmut | |
700 | 1 | _aWelte, Tobias | |
700 | 1 | _aZabel, Peter | |
773 | 0 |
_tThe Lancet. Infectious diseases _gvol. 5 _gno. 3 _gp. 147-55 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1473-3099(05)01307-1 _zAvailable from publisher's website |
999 |
_c15439407 _d15439407 |